	Wearable technologies for perioperative recovery monitoring in lung cancer surgery: a systematic review of feasibility, recovery outcomes, and evidence certainty. Front Oncol Lin X, Zhang J, Wang B, Dong Z, Tong Y, Zhou J, Liao H. PMID: 42318462 [PubMed]
	Integrated metabolomics and machine learning identify predictive biomarkers via SHAP analysis for sintilimab-induced rash in lung cancer patients. Front Pharmacol Tian W, Tang H, Liu X, Lv J, Xu Y, Hua Y, Xie F, Ding Y. PMID: 42318346 [PubMed]
	Mycophenolate mofetil for corticosteroid-resistant immune-related cystitis associated with tislelizumab: a case report. Front Immunol Kong L, Meng F, Yang J, Tang K, Xu J, Zhong D, Zhang L. PMID: 42317347 [PubMed - indexed for MEDLINE]
	Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance. Front Immunol Niu J, Jing W, Liu Z, Si Y, Liu Z. PMID: 42317338 [PubMed - indexed for MEDLINE]
	Effect of histology on the efficacy of first-line immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and network meta-analysis. Front Immunol Li S, He T, Chen J, Liu T, Zhao X, Dang J. PMID: 42317330 [PubMed - indexed for MEDLINE]
	Clinical exploration of first-line therapy in metastatic lung adenocarcinoma patients with negative or low PD-L1 expression: a retrospective cohort study. Front Immunol Xu K, Cai R, Sun Z, Wang C, Bao J. PMID: 42317329 [PubMed - indexed for MEDLINE]
	Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. Thorac Cancer Kotake M, Watanabe S, Sakai Y, Kikuchi T, Toyama A. PMID: 42316436 [PubMed - indexed for MEDLINE]
	Comparative efficacy of total en-bloc spondylectomy and separation surgery followed by stereotactic body radiotherapy for isolated spinal metastases in lung cancer patients: a retrospective study. BMC Surg Zhu Z, Yuan H, Shen Z, Liu H, Li B, Xu W. PMID: 42316097 [PubMed - as supplied by publisher]
	Differentiating sub-centimeter lung metastases in colorectal cancer by deep learning: a multicenter retrospective study. BMC Med Imaging Gao X, Ma X, Zhang Z, Yuan J, Li Q, Zheng P, Lv M, Ma D, Sun J. PMID: 42316047 [PubMed - as supplied by publisher]
	Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer. Pharmacoecon Open Wu YS, Burger EA, Holmboe F, Bangum M, Oteiza F, Bugge C, Sæther EM, Aas E. PMID: 42315785 [PubMed - as supplied by publisher]
	Journey Mapping of the Patient Experience from Diagnosis to End of Life in Lung Cancer: A Qualitative Meta-Synthesis. Semin Oncol Nurs Zhang F, Wang Y, Xiao Y, Li J, Liu Y, Li H, Wang Z, Li W. PMID: 42315410 [PubMed - as supplied by publisher]
	Mitochondrial DNA in Lung Cancer: from biology to clinical implications. Crit Rev Oncol Hematol Lucio-Lozada J, Prada D, Beato-González L, Hirsch FR, Cardona AF, Hernández-Pedro N, Arrieta O. PMID: 42314881 [PubMed - as supplied by publisher]
	Prospective study of proton beam therapy for non-small cell lung cancer patients with idiopathic pulmonary fibrosis. Radiother Oncol Shin H, Yang K, Yoo H, Park HY, Shin SH, Noh JM, Pyo H. PMID: 42314836 [PubMed - as supplied by publisher]
	Off-Protocol Radiotherapy in Prospective Systemic Therapy Trials for Metastatic Non-Small Cell Lung Cancer. Clin Lung Cancer Ruicci KM, Li GJ, Warner A, Youssef A, Parmar A, Mutsaers A, Palma DA, Louie AV. PMID: 42314501 [PubMed - as supplied by publisher]
	Corrigendum to "POU2F3 in Small Cell Lung Cancer (SCLC): Diagnostic Utility in Neuroendocrine-Low/Negative SCLC and Discrimination From Other Thoracic Malignancies and Other Small Blue Round Cell Tumors" [Laboratory Investigation 2026;106(6):106124]. Lab Invest Chen X, Zou F, Xu H, Zhang Z, Wang J, Li Y, Jia J, Sun S, Wang C, Zhang J. PMID: 42314383 [PubMed - as supplied by publisher]
	Mapping the evidence of stereotactic body radiotherapy combined with systemic therapy in oligometastatic and oligoprogressive non-small cell lung cancer: A visual synthesis of clinical outcomes and toxicity. Cancer Treat Res Commun Karagiannis V, Tolia M, Vomvas D, Mazonakis M, Shiarli AM, Saarinen J, Nåhls NS, Ntaskagiannis D, Morfo G, Jekunen A. PMID: 42314262 [PubMed - as supplied by publisher]
	Optimized Simultaneous N/O-Glycopeptide Enrichment Strategy Identifies Lung Cancer Diagnostic Biomarkers in Serum. J Proteome Res Zhou Z, Zhao J, Zhang J, Wu P, Yang Y, Li W, Peng C, Qiang Z. PMID: 42313501 [PubMed - as supplied by publisher]
	An overview of circular RNAs in the regulation of autophagy in lung cancer. Discov Oncol Rejili M, Abass KS, Hashemi F. PMID: 42313297 [PubMed - as supplied by publisher]
	Cisplatin versus carboplatin as adjuvant chemotherapy for completely resected non-small cell lung cancer: a multicenter retrospective cohort study. Surg Today Hamaji M, Miyata R, Takeuchi J, Ozu N, Kohama T, Sumitomo R, Takahashi M, Fukada T, Kobayashi M, Kumaya Y, Chen-Yoshikawa TF. PMID: 42313168 [PubMed - as supplied by publisher]
	First-Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK-Positive Non-Small Cell Lung Cancer with Brain Metastases: A Real-World Multicenter Study from Vietnam. Thorac Cancer Nguyen HG, Nguyen XH, Nguyen P, Nguyen TH, Vinh QB. PMID: 42313051 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159639

Page 1 of 7982



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy